OS Therapies OSTX
NYSE OSTX
$1.28 +0.01 (+0.78%)
As of: Oct 22, 2026 · 10:07 AM EDT

OS Therapies (OSTX) Ending Cash Balance (2023 - 2026)

Updated

Analysis

OS Therapies (OSTX) Ending Cash Balance (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn 20.42 Bn
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn 6.57 Bn
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn 4.88 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 1.03 Bn
10 OS Therapies 6.21 Mn 2.94 Mn - 205,035.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 205,035.00
Mar 31, 2026 917,552.00
Dec 31, 2025 269,830.00
Jun 30, 2025 2.80 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 5.53 Mn
Sep 30, 2024 1.86 Mn
Jun 30, 2024 94,925.00
Mar 31, 2024 100,231.00
Dec 31, 2023 38,982.00
Sep 30, 2023 16,059.00
Jun 30, 2023 49,222.00
Mar 31, 2023 355,214.00
API Access

OS Therapies Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=OSTX&period=max&api_key=YOUR_API_KEY